Next Article in Journal
Study on the Isolation of Two Atrazine-Degrading Bacteria and the Development of a Microbial Agent
Previous Article in Journal
Characterization a Novel Butyric Acid-Producing Bacterium Collinsella aerofaciens Subsp. Shenzhenensis Subsp. Nov.
Previous Article in Special Issue
Intracellular Bacterial Infections: A Challenge for Developing Cellular Mediated Immunity Vaccines for Farmed Fish
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessArticle

Multi-Level Model to Predict Antibody Response to Influenza Vaccine Using Gene Expression Interaction Network Feature Selection

Tandy School of Computer Science, University of Tulsa, Tulsa, OK 74104, USA
Mayo Vaccine Group, Mayo Clinic, Rochester, MN 55905, USA
Department of Mathematics, University of Tulsa, Tulsa, OK 74104, USA
Author to whom correspondence should be addressed.
Microorganisms 2019, 7(3), 79;
Received: 29 December 2018 / Revised: 24 February 2019 / Accepted: 8 March 2019 / Published: 14 March 2019
(This article belongs to the Special Issue Vaccine Informatics)
PDF [2825 KB, uploaded 14 March 2019]
  |     |  


Vaccination is an effective prevention of influenza infection. However, certain individuals develop a lower antibody response after vaccination, which may lead to susceptibility to subsequent infection. An important challenge in human health is to find baseline gene signatures to help identify individuals who are at higher risk for infection despite influenza vaccination. We developed a multi-level machine learning strategy to build a predictive model of vaccine response using pre−vaccination antibody titers and network interactions between pre−vaccination gene expression levels. The first-level baseline−antibody model explains a significant amount of variation in post-vaccination response, especially for subjects with large pre−existing antibody titers. In the second level, we clustered individuals based on pre−vaccination antibody titers to focus gene−based modeling on individuals with lower baseline HAI where additional response variation may be predicted by baseline gene expression levels. In the third level, we used a gene−association interaction network (GAIN) feature selection algorithm to find the best pairs of genes that interact to influence antibody response within each baseline titer cluster. We used ratios of the top interacting genes as predictors to stabilize machine learning model generalizability. We trained and tested the multi-level approach on data with young and older individuals immunized against influenza vaccine in multiple cohorts. Our results indicate that the GAIN feature selection approach improves model generalizability and identifies genes enriched for immunologically relevant pathways, including B Cell Receptor signaling and antigen processing. Using a multi-level approach, starting with a baseline HAI model and stratifying on baseline HAI, allows for more targeted gene−based modeling. We provide an interactive tool that may be extended to other vaccine studies. View Full-Text
Keywords: gene interaction; vaccine immune response; nested cross-validation gene interaction; vaccine immune response; nested cross-validation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Parvandeh, S.; Poland, G.A.; Kennedy, R.B.; McKinney, B.A. Multi-Level Model to Predict Antibody Response to Influenza Vaccine Using Gene Expression Interaction Network Feature Selection. Microorganisms 2019, 7, 79.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Microorganisms EISSN 2076-2607 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top